Literature DB >> 27263106

Surgical outcome of patients with lung cancer involving the left atrium.

Takuma Tsukioka1, Makoto Takahama2, Ryu Nakajima2, Michitaka Kimura2, Hidetoshi Inoue2, Ryoji Yamamoto2.   

Abstract

BACKGROUND: Pulmonary and left atrial resection is not yet an established treatment for patients with primary lung cancer involving the left atrium. We investigated the clinical course of patients with primary lung cancer involving the left atrium who were treated with pulmonary resection and partial atrial resection.
METHODS: From January 1996 to December 2013, 51 patients underwent extended resection for lung cancer that invaded the surrounding organs. Of these, we focused on 12 patients who underwent surgical treatment for lung cancer involving the left atrium. The clinical course of each of these patients was investigated retrospectively.
RESULTS: The most common histological subtype was squamous cell carcinoma. Pneumonectomy was performed in nine patients, and right middle and lower lobectomy was performed in three patients. Complete resection was performed in 11 patients (92 %). Postoperative complications were observed in four patients (33 %)-prolonged air leakage in two patients, broncho-pleural fistula in one patient, and empyema in one patient. There were no surgical deaths. This study involved seven patients with pathological N0-1 disease and five patients with pathological N2 disease. The postoperative 5-year survival rate was 46 % in all patients. The 5-year survival rates in patients with pathological N0-1 disease and N2 disease were 67 and 20 %, respectively.
CONCLUSION: Because treatment-related death was not observed and outcome was fair in patients with N0-1 disease, surgical resection for primary lung cancer involving the left atrium may be acceptable in selected patients. Further investigations are required to improve the outcome of surgical treatment for patients with primary lung cancer involving the left atrium.

Entities:  

Keywords:  Left atrium; Primary lung cancer; Surgical treatment

Mesh:

Substances:

Year:  2016        PMID: 27263106     DOI: 10.1007/s10147-016-0992-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  12 in total

Review 1.  Long-term survival after lung resection for non-small cell lung cancer with circulatory bypass: a systematic review.

Authors:  Ashok Muralidaran; Frank C Detterbeck; Daniel J Boffa; Zuoheng Wang; Anthony W Kim
Journal:  J Thorac Cardiovasc Surg       Date:  2011-08-23       Impact factor: 5.209

2.  Cardiopulmonary bypass and cell-saver technique in combined oncologic and cardiovascular surgery.

Authors:  R S Akchurin; M I Davidov; S A Partigulov; J B Brand; A A Shiriaev; M G Lepilin; I M Dolgov
Journal:  Artif Organs       Date:  1997-07       Impact factor: 3.094

3.  Surgical results and long-term follow-up of T(4)-non-small cell lung cancer invading the left atrium or the intrapericardial base of the pulmonary veins.

Authors:  Franco Stella; Andrea Dell'Amore; Guido Caroli; Giampiero Dolci; Nicola Cassanelli; Giulia Luciano; Fabio Davoli; Alessandro Bini
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-01-22

4.  Atrial resection for lung cancer: morbidity, mortality, and long-term follow-up.

Authors:  Andreas Kuehnl; Michael Lindner; Hans-Martin Hornung; Hauke Winter; Karl-Walter Jauch; Rudolf A Hatz; Christian Graeb
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

5.  Left atrial resection for T4 lung cancer without cardiopulmonary bypass: technical aspects and outcomes.

Authors:  Geraud Galvaing; Marie M Tardy; Lucie Cassagnes; Valinkini Da Costa; Jean Baptiste Chadeyras; Adel Naamee; Patrick Bailly; Edith Filaire; Bruno Pereira; Marc Filaire
Journal:  Ann Thorac Surg       Date:  2014-03-10       Impact factor: 4.330

Review 6.  Extended pneumonectomy with partial resection of the left atrium, without cardiopulmonary bypass, for lung cancer.

Authors:  Lorenzo Spaggiari; Massimiliano D' Aiuto; Giulia Veronesi; Giuseppe Pelosi; Tommaso de Pas; Gianpiero Catalano; Filippo de Braud
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

7.  Extended resection of the left atrium, great vessels, or both for lung cancer.

Authors:  R Tsuchiya; H Asamura; H Kondo; T Goya; T Naruke
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

8.  Surgical outcome of combined pulmonary and atrial resection for lung cancer.

Authors:  A Bobbio; P Carbognani; M Grapeggia; M Rusca; F Sartori; P Bobbio; F Rea
Journal:  Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 1.827

9.  Surgery on extracorporeal circulation in early and advanced non-small cell lung cancer.

Authors:  Matthias Kauffmann; Tobias Krüger; Hermann Aebert
Journal:  Thorac Cardiovasc Surg       Date:  2012-12-04       Impact factor: 1.827

Review 10.  Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer.

Authors:  Giovanni B Ratto; Roberta Costa; Giuseppe Vassallo; Antonella Alloisio; Paola Maineri; Paolo Bruzzi
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

View more
  4 in total

1.  Initial extended resection or neoadjuvant therapy for T4 non-small cell lung cancer-What is the evidence?

Authors:  Ilkka Ilonen; David R Jones
Journal:  Shanghai Chest       Date:  2018-10-11

Review 2.  Surgery for malignant lesions of the chest which extensively involved the mediastinum, lung, and heart.

Authors:  Yugo Tanaka; Daisuke Hokka; Hiroyuki Ogawa; Nahoko Shimizu; Takeshi Inoue; Hiroshi Tanaka; Yutaka Okita; Yoshimasa Maniwa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-05-24

Review 3.  Atrial resection for T4 non-small cell lung cancer with left atrium involvement: a systematic review and meta-analysis of survival.

Authors:  Shadi Hamouri; Nasr Alrabadi; Sebawe Syaj; Hassan Abushukair; Obada Ababneh; Leen Al-Kraimeen; Majd Al-Sous; Erich Hecker
Journal:  Surg Today       Date:  2022-01-09       Impact factor: 2.549

Review 4.  Extended pneumonectomy for advanced lung cancer with cardiovascular structural invasions.

Authors:  Shi-Min Yuan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-04-30       Impact factor: 0.332

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.